Effect of rapid influenza diagnostic testing on antiviral treatment decisions for patients with influenza-like illness: Southwestern U.S., May-December 2009

Public Health Reports

Volumn 129, Issue 4, 2014, Pages 322-327

  Suryaprasad, Anil ^a   Redd, John T ^b   Ricks, Philip M ^c   Podewils, Laura Jean ^c   Brett, Meghan ^d   Oski, Jane ^e   Minenna, Wanda ^b   Armao, Frank ^f   Vize, Barbara J ^b   Cheek, James E ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b INDIAN HEALTH SERVICE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e Tuba City Regional Health Care Corporation   (United States)

^f Winslow Indian Health Care Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADOLESCENT; ADULT; ADVERSE OUTCOME; ANTIVIRAL THERAPY; ARTICLE; CHILD; CLINICAL DECISION MAKING; FEMALE; FLU LIKE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RAPID INFLUENZA DIAGNOSTIC TEST; RAPID TEST; RISK ASSESSMENT; SEASON;

ADOLESCENT; ADULT; AGE FACTORS; ANTIVIRAL AGENTS; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; EARLY DIAGNOSIS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; PANDEMICS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SOCIOECONOMIC FACTORS; SOUTHWESTERN UNITED STATES; TIME FACTORS; YOUNG ADULT;

EID: 84902992890     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335491412900406     Document Type: Article

References (18)

1. Jernigan DB, Lindstrom SL, Johnson JR, Miller JD, Hoelscher M, Humes R, et al. Detecting 2009 pandemic influenza A (H1N1) virus infection: availability of diagnostic testing led to rapid pandemic response. Clin Infect Dis 2011;52 Suppl 1:S36-43.
2. Centers for Disease Control and Prevention (US). Interim guidance for the detection of novel influenza A virus using rapid influenza diagnostic tests. Atlanta: CDC; 2009. Also available from: URL: http://www.cdc.gov/h1n1flu/guidance/rapid_testing.htm [cited 2013 Feb 4].
3. Centers for Disease Control and Prevention (US). Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. Atlanta: CDC; 2009. Also available from: URL: http://www.cdc.gov/h1n1flu/recommendations.htm [cited 2013 Feb 4].
4. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus-United States, 2009. MMWR Morb Mortal Wkly Rep 2009;58(30):826-9.
5. Chu H, Lofgren ET, Halloran ME, Kuan PF, Hudgens M, Cole SR. Performance of rapid influenza H1N1 diagnostic tests: a metaanalysis. Influenza Other Respir Viruses 2012;6:80-6.
6. Vasoo S, Stevens J, Singh K. Rapid antigen tests for diagnosis of pandemic (swine) influenza A/H1N1. Clin Infect Dis 2009;49:1090-3.
7. Uyeki TM, Prasad R, Vukotich C, Stebbins S, Rinaldo CR, Ferng YH, et al. Low sensitivity of rapid diagnostic test for influenza. Clin Infect Dis 2009;48:e89-92.
8. Indian Health Service (US). IHS fiscal year 2010 user population estimates. Rockville (MD): IHS; 2010. Also available from: URL: http://www.ihs.gov/california/assets/File/Training/FY2010-MemoFinalUserPop.pdf [cited 2013 Feb 4].
9. Indian Health Service (US). Trends in Indian health: 2002-2003 edition. Rockville (MD): Department of Health and Human Services (US); 2003.
10. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2011;60(RR-1):1-24.
11. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Morb Mortal Wkly Rep 2009;58(RR-10):1-8.
12. Kumar A. Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is life. J Antimicrob Chemother 2011;66:959-63.
13. SAS Institute Inc. SAS®: Version 9.3. Cary (NC): SAS Institute Inc.; 2011.
14. Vijayan V, Jing J, Zangwill KM. Evaluation of diagnostic and therapeutic approaches for suspected influenza A(H1N1)pdm09 infection, 2009-2010. Emerg Infect Dis 2012;18:1414-21.
15. Dinnes J, Deeks J, Kunst H, Gibson A, Cummins E, Waugh N, et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 2007;11:1-196.
16. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009;361:1935-44.
17. Yu H, Feng Z, Uyeki TM, Liao Q, Zhou L, Feng L, et al. Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis 2011;52:457-65.
18. Higuera Iglesias AL, Kudo K, Manabe T, Corcho Berdugo AE, Corrales Baeza A, Alfaro Ramos L, et al. Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico. PLoS One 2011;6:e21838.